AU9092091A - Receptor recognition factor and methods of use thereof - Google Patents
Receptor recognition factor and methods of use thereofInfo
- Publication number
- AU9092091A AU9092091A AU90920/91A AU9092091A AU9092091A AU 9092091 A AU9092091 A AU 9092091A AU 90920/91 A AU90920/91 A AU 90920/91A AU 9092091 A AU9092091 A AU 9092091A AU 9092091 A AU9092091 A AU 9092091A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- receptor recognition
- recognition factor
- factor
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61332690A | 1990-11-14 | 1990-11-14 | |
US613326 | 1990-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9092091A true AU9092091A (en) | 1992-06-11 |
Family
ID=24456859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU90920/91A Abandoned AU9092091A (en) | 1990-11-14 | 1991-11-14 | Receptor recognition factor and methods of use thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU9092091A (en) |
WO (1) | WO1992008740A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3926893A (en) * | 1992-03-19 | 1993-10-21 | Rockefeller University, The | Ifn receptors recognition factors, protein sequences and methods of use thereof |
WO1994017180A1 (en) * | 1993-01-19 | 1994-08-04 | University Of Massachusetts Medical Center | Nuclear localized transcription factor kinases |
US6255059B1 (en) | 1993-03-31 | 2001-07-03 | Cadus Pharmaceutical Corporation | Methods for identifying G protein coupled receptor effectors |
US20030054402A1 (en) | 1993-03-31 | 2003-03-20 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
US6864060B1 (en) | 1993-03-31 | 2005-03-08 | Cadus Technologies, Inc. | Yeast cells expressing modified G proteins and methods of use therefor |
US6100042A (en) | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
US7235648B1 (en) | 1993-03-31 | 2007-06-26 | Cadus Technologies, Inc. | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
AU8072194A (en) * | 1993-09-24 | 1995-04-10 | Rockefeller University, The | Receptor recognition factors, protein sequences and methods of use thereof |
US5723300A (en) * | 1995-07-10 | 1998-03-03 | University Of Massachusetts Medical Center | Nuclear localized transcription factor kinase and diagnostic assays related thereto |
US6716435B1 (en) | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
US6355473B1 (en) | 1998-05-06 | 2002-03-12 | Cadus Pharmaceutical Corp. | Yeast cells having mutations in stp22 and uses therefor |
US7081360B2 (en) | 1998-07-28 | 2006-07-25 | Cadus Technologies, Inc. | Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
US7273747B2 (en) | 1998-08-27 | 2007-09-25 | Cadus Technologies, Inc. | Cell having amplified signal transduction pathway responses and uses therefor |
US6251605B1 (en) | 1998-10-27 | 2001-06-26 | Cadus Pharmaceutical Corporation | Yeast cells having mutations in Cav1 and uses therefor |
WO2000031261A2 (en) | 1998-11-25 | 2000-06-02 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor |
US6504008B1 (en) | 1999-02-01 | 2003-01-07 | Cadus Technologies, Inc. | Cell based signal generation |
US6555325B1 (en) | 1999-06-14 | 2003-04-29 | Cadus Technologies, Inc. | System for detection of a functional interaction between a compound and a cellular signal transduction component |
US7223533B2 (en) | 1999-09-10 | 2007-05-29 | Cadus Technologies, Inc. | Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways |
-
1991
- 1991-11-14 AU AU90920/91A patent/AU9092091A/en not_active Abandoned
- 1991-11-14 WO PCT/US1991/008529 patent/WO1992008740A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1992008740A3 (en) | 1992-08-06 |
WO1992008740A2 (en) | 1992-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU650522B2 (en) | Person and object recognition system | |
AU7991491A (en) | Highly reflective biogratings and method | |
AU9024491A (en) | Telecommunications booth and method of use | |
AU1209495A (en) | Human monoclonal antibodies against human cytokines and methods of making and using such antibodies | |
AU7435296A (en) | Novel expression vectors and methods of use | |
GR3022065T3 (en) | Novel antibodies and methods for their use | |
AU2199092A (en) | Prosthesis press and method of using the same | |
EP0521139A4 (en) | Adjustable sutures and methods of making and using same | |
AU9092091A (en) | Receptor recognition factor and methods of use thereof | |
AU3678489A (en) | Alloy and methods of use thereof | |
AU5669494A (en) | Human homolog of the e-cadherin gene and methods based thereon | |
AU1366088A (en) | Immunosuppressive peptides and methods of use | |
AU6710598A (en) | Improved methods for the determination and adjustment of prolactin daily rhythms | |
AU3937593A (en) | Trans-sialidase and methods of use and making thereof | |
AU7416191A (en) | Electrographic structure and process | |
AU8955691A (en) | Structural member and method of manufacture | |
AU2952192A (en) | Highlighting preparation and method of use | |
AU5641798A (en) | Artificial antibodies, method of producing the same and use thereof | |
AU7142891A (en) | Cable-stay roof and method of construction | |
AU633294B2 (en) | Motilin-like polypeptide and use thereof | |
AU5097790A (en) | Cyclopentenyl pyrimidines and methods of using same | |
AU8427091A (en) | Gamma-carboxylase and methods of use | |
AU631448B2 (en) | Application aid and the use thereof | |
AU647559B2 (en) | Pyrimidinyl- and triazinyl-salicylamides and their use and preparation | |
AU3422393A (en) | Novel RXR-containing heterodimers and method of use |